Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding ...

Altesa BioSciences, Inc., a clinical-stage pharmaceutical company dedicated to developing new treatments for viral infections in vulnerable populations, today announced that the U.S. Food and Drug ...

Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

Unfortunately, these drugs don't work for everyone ... benralizumab could become the first new therapy approved for ...

Global health projections indicate that COPD will affect ... properties of these medications may play a crucial role in protecting lung function, offering a new perspective on their therapeutic ...

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium ... as a maintenance treatment for chronic obstructive pulmonary disease (COPD). The drug has a marketing authorisation in a ...

A new study suggests COPD patients experience improved lung ... as both can be fearful of losing control of the disease in a change of medication. The CRYSTAL trial is the first large-scale ...

There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...

Regulatory Challenges: The approval of new asthma and COPD drugs often faces long and complicated regulatory processes. The stringent regulatory requirements in different regions, coupled with the ...